Michael A Fishbach

Title: Michael A. Fishbach: Innovator in Retroviral Research

Introduction

Michael A. Fishbach is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of retroviral research, particularly in the development of innovative pseudotyped retroviruses. His work has implications for various applications in virology and gene therapy.

Latest Patents

Michael A. Fishbach holds a patent for "Pseudotyped retroviruses and stable cell lines for their production." This invention involves cells that produce inventive pseudotyped retroviruses with a broad host range. The cells are capable of producing retroviruses pseudotyped with at least two different viral glycoproteins, such as togaviral glycoproteins. Additionally, the cells can produce retroviruses pseudotyped with filoviral glycoproteins. The patent also outlines methods for producing these cells and the pseudotyped retroviruses, as well as methods for screening agents that block viral entry into cells. Furthermore, it includes methods for using the pseudotyped retroviruses to introduce nucleotide sequences into target cells, along with kits for their formation. Michael A. Fishbach has 1 patent to his name.

Career Highlights

Michael A. Fishbach is associated with the Purdue Research Foundation, where he continues to advance his research in retroviral technologies. His work is characterized by a commitment to innovation and scientific excellence.

Collaborations

Some of his notable coworkers include Curtis M. Sharkey and Cynthia L. North. Their collaborative efforts contribute to the ongoing research and development in the field of retrovirology.

Conclusion

Michael A. Fishbach's contributions to the field of retroviral research highlight his innovative spirit and dedication to advancing scientific knowledge. His work on pseudotyped retroviruses has the potential to impact various areas of medical research and therapy.